Rachel Scott, DO
Colon & Rectal Surgery · Bloomfield, CTNPI 1184915860
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (60.0%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 91.4% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $4,698, more than ten times the $14 reported in 2020.
Across 36 payments — averaging $138.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Takeda Pharmaceuticals U.S.A., Inc.$159
- Ironwood Pharmaceuticals, Inc$87
- Axonics, Inc.$52
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$45
- Boston Scientific$23
- plus $66 from 4 others
What the payments were for
- Travel & lodging$1,36327%
- Food & beverage$63813%
- Education$3,00060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 14 | $4,569 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $159 |
| Ironwood Pharmaceuticals, Inc | 4 | $87 |
| Axonics, Inc. | 3 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Boston Scientific | 1 | $23 |
| Johnson & Johnson | 1 | $18 |
| Vioptix Inc | 1 | $16 |
| AbbVie | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$3,000
- Da Vinci Surgical System$1,368
How this compares
$5,001 in reported general payments places this provider in the 75th percentile of 48 colon & rectal surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 56 | $3,152 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 33 | $370 |
| Neomycin Sulfate | 17 | $80 |
| Metronidazole | 17 | $26 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Bloomfield
- Robert LewisBloomfield$4K
- Amanda AyersBloomfield$3K
- Daniel MullinsBloomfield$3K
- Andrew RaissisBloomfield$1K
- Jonathan ChangBloomfield$1K
- David WaltersBloomfield$500
- Saumitra BanerjeeBloomfield$205
- Vanessa BarattaBloomfield$76
- John MonsonDanbury$182K
- George YavorekNew Haven$45K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.